Company intelligence / Profile preview

CROMSOURCE

Ownership: Private
Employees: ~350
Development stage: Commercial

Overview

CROMSOURCE delivers full-service clinical research and flexible resourcing solutions for pharmaceutical, biotechnology and medical device companies globally. It has supported over 1,500 studies across multiple therapeutic areas prior to its acquisition by ClinChoice in March 2023.

Therapeutic areas: Metabolic DisordersOncologyPulmonologyRare DiseasesOphthalmologyNeurology
Modalities: Small moleculesBiologicsMedical devices
Industry: Contract Research Organization

Beyond the preview

Go deeper on CROMSOURCE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CROMSOURCE.

Explore the full profile